MEDIAN Technologies to take part in The Annual 2012 Conference of RSNA in Chicago

Regulatory News:

MEDIAN TECHNOLOGIES (Paris:ALMDT), a leading medical imaging software developer and service provider for oncology clinical trials and routine radiological practice, will participate in the 98^th Annual Meeting of the Radiological Society of North America (RSNA), to be held next Nov. 25 – 30, in Chicago, USA.

MEDIAN Lesion Management Solutions (LMS) for CT imaging, as well as new prototypes of clinical applications for other imaging modalities, will be presented in the MEDIAN booth 5245, French Pavilion, South Building, Hall A all along the conference.

The Annual Meeting of the Radiological Society of North America is the worldwide scientific and technical meeting of the medical imaging professional community. More than 60.000 professionals of the medical imaging will attend.

About MEDIAN Technologies: MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice. MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA. MEDIAN has a strategic partnership with Canon, for the development of new technologies, and with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 45, over half of whom work in R&D, and a US-based subsidiary. For more information on MEDIAN, please visit: www.mediantechnologies.com